We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Prosperity Bancshares
PB
$8.82B
| $9.88M | 0.04% |
148,971
-678
| -0.5% | -$46.6K |
|
302
Universal Insurance Holdings
UVE
$1.23B
| $9.78M | 0.04% |
371,982
+41,830
| +13% | +$1.03M |
|
303
Vertex Pharmaceuticals
VRTX
$124B
| $9.77M | 0.04% |
24,949
-26,007
| -51% | -$10.9M |
|
304
Live Oak Bancshares
LOB
$1.99B
| $9.74M | 0.04% |
276,667
-5,683
| -2% | -$196K |
|
305
Jefferies Financial Group
JEF
$13.2B
| $9.74M | 0.04% |
+148,843
| New | +$9.08M |
|
306
Employers Holdings
EIG
$912M
| $9.72M | 0.04% |
228,813
+4,417
| +2% | +$192K |
|
307
Keros Therapeutics
KROS
$199M
| $9.6M | 0.04% |
607,089
+82,749
| +16% | +$1.22M |
|
308
Morgan Stanley
MS
$333B
| $9.56M | 0.04% |
60,112
-13,242
| -18% | -$1.96M |
|
309
Scholastic
SCHL
$766M
| $9.53M | 0.04% |
347,914
-120,600
| -26% | -$2.98M |
|
310
Par Pacific Holdings
PARR
$3.97B
| $9.49M | 0.04% |
267,944
+249,982
| +1,392% | +$8.13M |
|
311
Ardagh Metal Packaging
AMBP
$3.11B
| $9.41M | 0.04% |
2,357,953
+2,022,889
| +604% | +$8.05M |
|
312
AutoZone
AZO
$50.9B
| $9.34M | 0.04% |
2,176
-239
| -10% | -$959K |
|
313
Dyne Therapeutics
DYN
$4.28B
| $9.23M | 0.04% |
+729,606
| New | +$8.32M |
|
314
MDU Resources
MDU
$4.31B
| $9.17M | 0.04% |
514,603
-357,732
| -41% | -$5.97M |
|
315
Braze
BRZE
$2.83B
| $9.15M | 0.04% |
+321,688
| New | +$9.12M |
|
316
Affiliated Managers Group
AMG
$9.78B
| $9.14M | 0.04% |
38,355
-62,067
| -62% | -$13.7M |
|
|
CVGW
317
DELISTED
Calavo Growers
CVGW
| $9.09M | 0.04% |
353,136
-27,311
| -7% | -$737K |
|
318
Helen of Troy
HELE
$672M
| $9.06M | 0.04% |
359,693
+15,730
| +5% | +$381K |
|
319
Workday
WDAY
$39.4B
| $9M | 0.04% |
+37,383
| New | +$8.64M |
|
320
Vestis
VSTS
$2.03B
| $8.88M | 0.04% |
1,960,150
+1,816,633
| +1,266% | +$9.31M |
|
321
Grid Dynamics Holdings
GDYN
$513M
| $8.85M | 0.04% |
+1,148,331
| New | +$10.2M |
|
322
IDT Corp
IDT
$1.69B
| $8.85M | 0.04% |
169,146
+135,894
| +409% | +$8.47M |
|
323
Exponent
EXPO
$3.15B
| $8.81M | 0.04% |
126,840
-744
| -0.6% | -$53.2K |
|
324
LegalZoom.com
LZ
$1.39B
| $8.76M | 0.03% |
843,846
-1,361,279
| -62% | -$13.6M |
|
325
Credo Technology Group
CRDO
$35.9B
| $8.62M | 0.03% |
59,231
+26,116
| +79% | +$3.2M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.